(Q45768072)

15 December 2017

title

Preoperative serum CA 125 level as a predictor for metastasis and survival in endometrioid endometrial cancer (English)

1 reference

15 December 2017

Mucin 16, cell surface associated

main subject

1 reference

inferred from title

author name string

B Pinar Cilesiz Goksedef

1

1 reference

15 December 2017

Husnu Gorgen

2

1 reference

15 December 2017

Safak Yilmaz Baran

3

1 reference

15 December 2017

Murat Api

4

1 reference

15 December 2017

Ahmet Cetin

5

1 reference

15 December 2017

language of work or name

1 reference

1 August 2011

1 reference

15 December 2017

Journal of Obstetrics and Gynaecology Canada

published in

1 reference

15 December 2017

volume

33

1 reference

15 December 2017

issue

8

1 reference

15 December 2017

page(s)

844-850

1 reference

15 December 2017

Surgical pathologic spread patterns of endometrial cancer. A Gynecologic Oncology Group Study

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

CA 125: a useful marker in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Predictive value of preoperative serum CA 125 levels in clinically localized and advanced endometrial carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Value of preoperative CA 125 level in the management of uterine cancer and prediction of clinical outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Elevation of serum CA125 in carcinomas of the fallopian tube, endometrium, and endocervix

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Preoperative CA 125 in endometrial cancer: is it useful?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Is OVX1 a suitable marker for endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Tissue and serum CA125 expression in endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Use of preoperative serum CA-125 levels for prediction of lymph node metastasis and prognosis in endometrial cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Combined use of magnetic resonance imaging, CA 125 assay, histologic type, and histologic grade in the prediction of lymph node metastasis in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Can a preoperative CA 125 level be a criterion for full pelvic lymphadenectomy in surgical staging of endometrial cancer?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Multiple serum markers in patients with endometrial cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Combined use of CA 125 and CA 15-3 in patients with endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Combined assay of serum levels of CA125 and CA19-9 in endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Tumor marker CA 125 level and ovarian volume at different cycle day periods and in postmenopause

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Prospective evaluation of serum CA 125 levels in a normal population, phase I: the specificities of single and serial determinations in testing for ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

What is a normal CA125 level?

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Determination of a normal level of serum CA125 in postmenopausal women as a tool for preoperative evaluation and postoperative surveillance of endometrial carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Efficacy of systematic lymphadenectomy and adjuvant radiotherapy in node-positive endometrial cancer patients

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

FIGO stage IIIC endometrial carcinoma: resection of macroscopic nodal disease and other determinants of survival

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Retrospective Analysis of Selective Lymphadenectomy in Apparent Early-Stage Endometrial Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium

1 reference

https://api.crossref.org/works/10.1016%2FS1701-2163%2816%2934988-X

7 January 2021

10.1016/S1701-2163(16)34988-X

Identifiers

DOI

1 reference

15 December 2017

1 reference

15 December 2017